Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 6.Implementation of Every Student Succeeds Act (Public Law 114-95) 7.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 8.FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 9.FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 10.FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 11.FY2020 Further Consolidated Appropriations Act (H.R. 1865/P.L. 116-94) 12.Midnight Rules Relief Act (S.34/H.R. 21) 13.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16.Regulatory Integrity Act (H.R. 1004) 17.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19.American Health Care Act (H.R. 1628/H.Res. 228) 20.Ozone Standards Implementation Act (S. 263/H.R. 806) 21.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25.Preventing Antibiotic Resistance Act (S. 629) 26.Better Care Reconciliation Act (H.R. 1628) and related amendments 27.Public Health Emergency Response Act (S. 196) 28.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29.Consolidated Appropriations Act, 2017 (Public Law 115-31) 30.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33.Tobacco Tax Equity Act (S. 1837) 34.Healthy Kids Act (S. 1821/H.R. 3921) 35.Implementation of the Drug Quality and Security Act (P.S. 113-54) 36.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38.Lead-Safe Housing for Kids Act (S. 1845) 39.Supporting Working Moms Act (S. 2122/H.R. 3255) 40.Championing Healthy Kids Act (H.R. 3922) 41.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 43.Tax Cuts and Jobs Act (Public Law 115-97) 44.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45.Vaccine Access Improvement Act (H.R. 4993) 46.Relief from New Source Performance Standards Act (H.R. 453) 47.Strategies to Address Antimicrobial Resistance (S. 2469) 48.Opioid Quota Reform Act (S. 2535) 49.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51.Opioid Crisis Response Act of 2018 (S. 2680) 52.Agriculture and Nutrition Act (H.R. 2) 53.Agriculture Improvement Act (S. 3042) 54.SECURE Act (H.R. 5998) 55.Trauma-Informed Care for Children and Families Act (S. 774) 56.SUPPORT for Patients and Communities Act (H.R. 6) 57.Centers for Disease Control Emergency Response Act (S. 3161) 58.LABEL Opioids Act (S. 3428) 59.Relief from New Source Performance Standards Act (S. 1857) 60.Outdoors for All Act (S. 3499) 61.The MOMMA Act (H.R. 5977) 62.Preventing Maternal Deaths Act (H.R. 1318) 63.Medicare Access to Vaccines Equity Act (note yet introduced) 64.The Support Act (H.R. 6) 65.Climate Change Health Protection and Promotion Act (S. 529) 66.FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 67.NURSE Act (H.R. 1597) 68.Investing for the People Act (H.R. 2021) 69.Child Care for Working Families Act (H.R. 365/S. 568) 70.FAMILY Act (H.R. 1185/S. 463) 71.Transportation Alternatives Enhancement Act (S. 1098) 72.Lower Health Care Costs Act (S. 1895) 73.LIFT America Act (H.R 2479) 74.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 75.Older Americans Act reauthorization (not yet introduced) 76.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 77.Healthier Students for Stronger Campuses Act (S. 1281) 78.Saving Lives Through Better Data Act (S. 1793) 79.VACCINES Act (H.R. 2862) 80.DISARM Act (H.R. 4100/S. 1712) 81.Community Access, Resources, and Education for Families Act (H.R. 3117) 82.Protecting Seniors Through Immunization Act (S. 1872) 83.Tobacco-Free Youth Act (S. 1541) 84.Tobacco to 21 Act (H.R. 2411/S. 1258) 85.Investing for People Act (H.R. 2021) 86.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 87.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 88.Social Determinants Accelerator Act (H.R. 4004) 89.Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 90.The UNDERSTAND Act (S. 1323) 91.Americas Transportation Infrastructure Act (S. 2302) 92.Health Equity and Accountability Act (Not yet introduced) 93.Barriers to Suicide Act of 2019 (H.R. 4309) 94.Promoting Physical Activity for Americans Act (S. 1608) 95.Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 96.Supporting Healthy Mothers and Infants Act (H.R. 5249) 97.Lead-Free Future Act (H.R. 4416) 98.Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 99.Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H.Res. 592) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA.

Client expense: $35,486 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 7.Implementation of Every Student Succeeds Act (Public Law 114-95) 8.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 9.FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 10.FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 11.FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 12.Midnight Rules Relief Act (S.34/H.R. 21) 13.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16.Regulatory Integrity Act (H.R. 1004) 17.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19.American Health Care Act (H.R. 1628/H.Res. 228) 20.Ozone Standards Implementation Act (S. 263/H.R. 806) 21.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25.Preventing Antibiotic Resistance Act (S. 629) 26.Better Care Reconciliation Act (H.R. 1628) and related amendments 27.Public Health Emergency Response Act (S. 196) 28.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29.Consolidated Appropriations Act, 2017 (Public Law 115-31) 30.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33.Tobacco Tax Equity Act (S. 1837) 34.Healthy Kids Act (S. 1821/H.R. 3921) 35.Implementation of the Drug Quality and Security Act (P.S. 113-54) 36.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38.Lead-Safe Housing for Kids Act (S. 1845) 39.Supporting Working Moms Act (S. 2122/H.R. 3255) 40.Championing Healthy Kids Act (H.R. 3922) 41.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 43.Tax Cuts and Jobs Act (Public Law 115-97) 44.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45.Vaccine Access Improvement Act (H.R. 4993) 46.Relief from New Source Performance Standards Act (H.R. 453) 47.Strategies to Address Antimicrobial Resistance (S. 2469) 48.Opioid Quota Reform Act (S. 2535) 49.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51.Health Equity and Accountability Act (H.R. 5942) 52.Opioid Crisis Response Act of 2018 (S. 2680) 53.Agriculture and Nutrition Act (H.R. 2) 54.Agriculture Improvement Act (S. 3042) 55.SECURE Act (H.R. 5998) 56.Trauma-Informed Care for Children and Families Act (S. 774) 57.SUPPORT for Patients and Communities Act (H.R. 6) 58.Centers for Disease Control Emergency Response Act (S. 3161) 59.LABEL Opioids Act (S. 3428) 60.Relief from New Source Performance Standards Act (S. 1857) 61.Outdoors for All Act (S. 3499) 62.The MOMMA Act (H.R. 5977) 63.Preventing Maternal Deaths Act (H.R. 1318) 64.Medicare Access to Vaccines Equity Act (note yet introduced) 65.The Support Act (H.R. 6) 66.Climate Change Health Protection and Promotion Act (S. 529) 67.FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 68.NURSE Act (H.R. 1597) 69.Investing for the People Act (H.R. 2021) 70.Child Care for Working Families Act (H.R. 365/S. 568) 71.FAMILY Act (H.R. 1185/S. 463) 72.Transportation Alternatives Enhancement Act (S. 1098) 73.Lower Health Care Costs Act (S. 1895) 74.LIFT America Act (H.R 2479) 75.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 76.Older Americans Act reauthorization (not yet introduced) 77.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 78.Healthier Students for Stronger Campuses Act (S. 1281) 79.Saving Lives Through Better Data Act (S. 1793) 80.VACCINES Act (H.R. 2862) 81.DISARM Act (S. 1712/not yet introduced) 82.Community Access, Resources, and Education for Families Act (H.R. 3117) 83.Protecting Seniors Through Immunization Act (S. 1872) 84.Tobacco-Free Youth Act (S. 1541) 85.Tobacco to 21 Act (H.R. 2411/S. 1258) 86.Investing for People Act (H.R. 2021) 87.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 88.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 7.Implementation of Every Student Succeeds Act (Public Law 114-95) 8.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 9.FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 10.FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 11.FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 12.Midnight Rules Relief Act (S.34/H.R. 21) 13.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16.Regulatory Integrity Act (H.R. 1004) 17.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19.American Health Care Act (H.R. 1628/H.Res. 228) 20.Ozone Standards Implementation Act (S. 263/H.R. 806) 21.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25.Preventing Antibiotic Resistance Act (S. 629) 26.Better Care Reconciliation Act (H.R. 1628) and related amendments 27.Public Health Emergency Response Act (S. 196) 28.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29.Consolidated Appropriations Act, 2017 (Public Law 115-31) 30.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33.Tobacco Tax Equity Act (S. 1837) 34.Healthy Kids Act (S. 1821/H.R. 3921) 35.Implementation of the Drug Quality and Security Act (P.S. 113-54) 36.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38.Lead-Safe Housing for Kids Act (S. 1845) 39.Supporting Working Moms Act (S. 2122/H.R. 3255) 40.Championing Healthy Kids Act (H.R. 3922) 41.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 43.Tax Cuts and Jobs Act (Public Law 115-97) 44.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45.Vaccine Access Improvement Act (H.R. 4993) 46.Relief from New Source Performance Standards Act (H.R. 453) 47.Strategies to Address Antimicrobial Resistance (S. 2469) 48.Opioid Quota Reform Act (S. 2535) 49.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51.Health Equity and Accountability Act (H.R. 5942) 52.Opioid Crisis Response Act of 2018 (S. 2680) 53.Agriculture and Nutrition Act (H.R. 2) 54.Agriculture Improvement Act (S. 3042) 55.SECURE Act (H.R. 5998) 56.Trauma-Informed Care for Children and Families Act (S. 774) 57.SUPPORT for Patients and Communities Act (H.R. 6) 58.Centers for Disease Control Emergency Response Act (S. 3161) 59.LABEL Opioids Act (S. 3428) 60.Relief from New Source Performance Standards Act (S. 1857) 61.Outdoors for All Act (S. 3499) 62.The MOMMA Act (H.R. 5977) 63.Preventing Maternal Deaths Act (H.R. 1318) 64.Medicare Access to Vaccines Equity Act (note yet introduced) 65.The Support Act (H.R. 6) 66.Climate Change Health Protection and Promotion Act (S. 529) 67.FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 68.NURSE Act (H.R. 1597) 69.Investing for the People Act (H.R. 2021) 70.Child Care for Working Families Act (H.R. 365/S. 568) 71.FAMILY Act (H.R. 1185/S. 463) 72.Transportation Alternatives Enhancement Act (S. 1098) 73.Lower Health Care Costs Act (S. 1895) 74.LIFT America Act (H.R 2479) 75.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 76.Older Americans Act reauthorization (not yet introduced) 77.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 78.Healthier Students for Stronger Campuses Act (S. 1281) 79.Saving Lives Through Better Data Act (S. 1793) 80.VACCINES Act (H.R. 2862) 81.DISARM Act (S. 1712/not yet introduced) 82.Community Access, Resources, and Education for Families Act (H.R. 3117) 83.Protecting Seniors Through Immunization Act (S. 1872) 84.Tobacco-Free Youth Act (S. 1541) 85.Tobacco to 21 Act (H.R. 2411/S. 1258) 86.Investing for People Act (H.R. 2021) 87.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 88.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 7.Implementation of Every Student Succeeds Act (Public Law 114-95) 8.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 9.FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 10.FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 11.FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 12.Midnight Rules Relief Act (S.34/H.R. 21) 13.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16.Regulatory Integrity Act (H.R. 1004) 17.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19.American Health Care Act (H.R. 1628/H.Res. 228) 20.Ozone Standards Implementation Act (S. 263/H.R. 806) 21.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25.Preventing Antibiotic Resistance Act (S. 629) 26.Better Care Reconciliation Act (H.R. 1628) and related amendments 27.Public Health Emergency Response Act (S. 196) 28.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29.Consolidated Appropriations Act, 2017 (Public Law 115-31) 30.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33.Tobacco Tax Equity Act (S. 1837) 34.Healthy Kids Act (S. 1821/H.R. 3921) 35.Implementation of the Drug Quality and Security Act (P.S. 113-54) 36.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38.Lead-Safe Housing for Kids Act (S. 1845) 39.Supporting Working Moms Act (S. 2122/H.R. 3255) 40.Championing Healthy Kids Act (H.R. 3922) 41.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 43.Tax Cuts and Jobs Act (Public Law 115-97) 44.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45.Vaccine Access Improvement Act (H.R. 4993) 46.Relief from New Source Performance Standards Act (H.R. 453) 47.Strategies to Address Antimicrobial Resistance (S. 2469) 48.Opioid Quota Reform Act (S. 2535) 49.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51.Health Equity and Accountability Act (H.R. 5942) 52.Opioid Crisis Response Act of 2018 (S. 2680) 53.Agriculture and Nutrition Act (H.R. 2) 54.Agriculture Improvement Act (S. 3042) 55.SECURE Act (H.R. 5998) 56.Trauma-Informed Care for Children and Families Act (S. 774) 57.SUPPORT for Patients and Communities Act (H.R. 6) 58.Centers for Disease Control Emergency Response Act (S. 3161) 59.LABEL Opioids Act (S. 3428) 60.Relief from New Source Performance Standards Act (S. 1857) 61.Outdoors for All Act (S. 3499) 62.The MOMMA Act (H.R. 5977) 63.Preventing Maternal Deaths Act (H.R. 1318) 64.Medicare Access to Vaccines Equity Act (note yet introduced) 65.The Support Act (H.R. 6) 66.Climate Change Health Protection and Promotion Act (S. 529) 67.FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 68.NURSE Act (H.R. 1597) 69.Investing for the People Act (H.R. 2021) 70.Child Care for Working Families Act (H.R. 365/S. 568) 71.FAMILY Act (H.R. 1185/S. 463) 72.Transportation Alternatives Enhancement Act (S. 1098) 73.Lower Health Care Costs Act (S. 1895) 74.LIFT America Act (H.R 2479) 75.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 76.Older Americans Act reauthorization (not yet introduced) 77.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 78.Healthier Students for Stronger Campuses Act (S. 1281) 79.Saving Lives Through Better Data Act (S. 1793) 80.VACCINES Act (H.R. 2862) 81.DISARM Act (S. 1712/not yet introduced) 82.Community Access, Resources, and Education for Families Act (H.R. 3117) 83.Protecting Seniors Through Immunization Act (S. 1872) 84.Tobacco-Free Youth Act (S. 1541) 85.Tobacco to 21 Act (H.R. 2411/S. 1258) 86.Investing for People Act (H.R. 2021) 87.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 88.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2. Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3. Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4. Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5. Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6. Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7. Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8. Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9. Implementation of Every Student Succeeds Act (Public Law 114-95) 10. Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11. FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12. FY 2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13. Consolidated Appropriations Act 2018 (Public Law 115-141) 14. Midnight Rules Relief Act (S.34/H.R. 21) 15. Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16. Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17. Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18. Regulatory Integrity Act (H.R. 1004) 19. OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20. A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21. American Health Care Act (H.R. 1628/H.Res. 228) 22. Ozone Standards Implementation Act (S. 263/H.R. 806) 23. Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24. Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25. Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26. Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27. Preventing Antibiotic Resistance Act (S. 629) 28. Better Care Reconciliation Act (H.R. 1628) and related amendments 29. Public Health Emergency Response Act (S. 196) 30. Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31. Consolidated Appropriations Act, 2017 (Public Law 115-31) 32. Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33. Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34. Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35. Tobacco Tax Equity Act (S. 1837) 36. Healthy Kids Act (S. 1821/H.R. 3921) 37. Implementation of the Drug Quality and Security Act (P.S. 113-54) 38. Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39. Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40. Lead-Safe Housing for Kids Act (S. 1845) 41. Supporting Working Moms Act (S. 2122/H.R. 3255) 42. Championing Healthy Kids Act (H.R. 3922) 43. Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 44. An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45. Tax Cuts and Jobs Act (Public Law 115-97) 46. Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328) 47. Vaccine Access Improvement Act (H.R. 4993) 48. Relief from New Source Performance Standards Act (H.R. 453) 49. Strategies to Address Antimicrobial Resistance (S. 2469) 50. Opioid Quota Reform Act (S. 2535) 51. Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52. Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 53. Health Equity and Accountability Act (H.R. 5942) 54. Opioid Crisis Response Act of 2018 (S. 2680) 55. Agriculture and Nutrition Act (H.R. 2) 56. Agriculture Improvement Act (S. 3042) 57. SECURE Act (H.R. 5998) 58. FY 2019 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 3158) 59. FY 2019 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 6147/S. 3073) 60. FY 2019 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 5961/ S. 2976) 61. Trauma-Informed Care for Children and Families Act (S. 774) 62. SUPPORT for Patients and Communities Act (H.R. 6) 63. Centers for Disease Control Emergency Response Act (S. 3161) 64. LABEL Opioids Act (S. 3428) 65. Relief from New Source Performance Standards Act (S. 1857) 66. Outdoors for All Act (S. 3499) 67. The MOMMA Act (H.R. 5977) 68. The WIC Act (not yet introduced) 69. Preventing Maternal Deaths Act (H.R. 1318) 70. Medicare Access to Vaccines Equity Act (note yet introduced) 71. The Support Act (H.R. 6) 72. Climate Change Health Protection and Promotion Act (S. 529) 73. FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act 74. NURSE Act (H.R. 1597) 75. Investing for the People Act (H.R. 2021) 76. Child Care for Working Families Act (H.R. 365/S. 568) 77. FAMILY Act (H.R. 1185/S. 463) 78. Transportation Alternatives Enhancement Act (S. 1098) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11.FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12.FY 2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13.Consolidated Appropriations Act 2018 (Public Law 115-141) 14.Midnight Rules Relief Act (S.34/H.R. 21) 15.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18.Regulatory Integrity Act (H.R. 1004) 19.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21.American Health Care Act (H.R. 1628/H.Res. 228) 22.Ozone Standards Implementation Act (S. 263/H.R. 806) 23.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27.Preventing Antibiotic Resistance Act (S. 629) 28.Better Care Reconciliation Act (H.R. 1628) and related amendments 29.Public Health Emergency Response Act (S. 196) 30.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31.Consolidated Appropriations Act, 2017 (Public Law 115-31) 32.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35.Tobacco Tax Equity Act (S. 1837) 36.Healthy Kids Act (S. 1821/H.R. 3921) 37.Implementation of the Drug Quality and Security Act (P.S. 113-54) 38.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40.Lead-Safe Housing for Kids Act (S. 1845) 41.Supporting Working Moms Act (S. 2122/H.R. 3255) 42.Championing Healthy Kids Act (H.R. 3922) 43.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 44.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45.Tax Cuts and Jobs Act (Public Law 115-97) 46.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6783) 47.Vaccine Access Improvement Act (H.R. 4993) 48.Relief from New Source Performance Standards Act (H.R. 453) 49.Strategies to Address Antimicrobial Resistance (S. 2469) 50.Opioid Quota Reform Act (S. 2535) 51.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52.Relief from New Source Performance Standards Act (H.R. 453) 53.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 54.Health Equity and Accountability Act (H.R. 5942) 55.Opioid Crisis Response Act of 2018 (S. 2680) 56.Agriculture and Nutrition Act (H.R. 2) 57.Agriculture Improvement Act (S. 3042) 58.SECURE Act (H.R. 5998) 59.FY 2019 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 3158) 60.FY 2019 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 6147/S. 3073) 61.FY 2019 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 5961/ S. 2976) 62.Trauma-Informed Care for Children and Families Act (S. 774) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2. Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3. Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4. Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5. Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6. Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7. Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8. Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9. Implementation of Every Student Succeeds Act (Public Law 114-95) 10. Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11. FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12. FY 2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13. Consolidated Appropriations Act 2018 (Public Law 115-141) 14. Midnight Rules Relief Act (S.34/H.R. 21) 15. Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16. Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17. Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18. Regulatory Integrity Act (H.R. 1004) 19. OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20. A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21. American Health Care Act (H.R. 1628/H.Res. 228) 22. Ozone Standards Implementation Act (S. 263/H.R. 806) 23. Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24. Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25. Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26. Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27. Preventing Antibiotic Resistance Act (S. 629) 28. Better Care Reconciliation Act (H.R. 1628) and related amendments 29. Public Health Emergency Response Act (S. 196) 30. Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31. Consolidated Appropriations Act, 2017 (Public Law 115-31) 32. Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33. Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34. Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35. Tobacco Tax Equity Act (S. 1837) 36. Healthy Kids Act (S. 1821/H.R. 3921) 37. Implementation of the Drug Quality and Security Act (P.S. 113-54) 38. Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39. Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40. Lead-Safe Housing for Kids Act (S. 1845) 41. Supporting Working Moms Act (S. 2122/H.R. 3255) 42. Championing Healthy Kids Act (H.R. 3922) 43. Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 44. An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45. Tax Cuts and Jobs Act (Public Law 115-97) 46. Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328) 47. Vaccine Access Improvement Act (H.R. 4993) 48. Relief from New Source Performance Standards Act (H.R. 453) 49. Strategies to Address Antimicrobial Resistance (S. 2469) 50. Opioid Quota Reform Act (S. 2535) 51. Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52. Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 53. Health Equity and Accountability Act (H.R. 5942) 54. Opioid Crisis Response Act of 2018 (S. 2680) 55. Agriculture and Nutrition Act (H.R. 2) 56. Agriculture Improvement Act (S. 3042) 57. SECURE Act (H.R. 5998) 58. FY 2019 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 3158) 59. FY 2019 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 6147/S. 3073) 60. FY 2019 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 5961/ S. 2976) 61. Trauma-Informed Care for Children and Families Act (S. 774) 62. SUPPORT for Patients and Communities Act (H.R. 6) 63. Centers for Disease Control Emergency Response Act (S. 3161) 64. LABEL Opioids Act (S. 3428) 65. Relief from New Source Performance Standards Act (S. 1857) 66. Outdoors for All Act (S. 3499) 67. The MOMMA Act (H.R. 5977) 68. The WIC Act (not yet introduced) 69. Preventing Maternal Deaths Act (H.R. 1318) 70. Medicare Access to Vaccines Equity Act (note yet introduced) 71. The Support Act (H.R. 6) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

340B Drug Discount Program ---Program Implementation & Oversight ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 4710: 340B Pause Act ---H.R. 5598: 340B Optimization Act Access to Medicines/World Health Organization Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA) ---H.R. 7328: Pandemic and All-Hazards Preparedness and Innovation Act of 2018 ---National Biodefense Strategy ---Gene Editing Biosimilars ---Access to Samples for Testing ---Coding ---Naming ---Interchangeability and Pharmacy Substitution ---S. 974/H.R. 2212: CREATES Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Patient-Focused Drug Development ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---FDA Management & Financial Accountability ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act ---S.771: Improving Access to Affordable Prescription Drugs ---General Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---Counterfeiting Drug Pricing ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Funding for Antimicrobial Resistance Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---FY 2020 Labor, HHS, Education Appropriations (Discussion Draft House/Senate) Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---S. 974/H.R. 2212: CREATES Act of 2017 ---H.R. 749: Lower Drug Costs Through Competition Act ---Incentives for Generic Drug Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations The United States-Mexico-Canada Agreement ---Pricing and Reimbursement Provisions ---IP Provisions ---Regulatory Harmonization US-UK Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization US-EU Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization US-Japan Trade Agreement ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Orphan Drug Issues ---Tax Credit Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Trade and Foreign Drug Price Controls Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education ---Vaccine Quality Measure Diagnostic and Personalized Medicine Regulation and Oversight Precision Medicine Initiative

340B Drug Discount Program ---Program Implementation & Oversight ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 4710: 340B Pause Act ---H.R. 5598: 340B Optimization Act ---S. 2453: Ensuring the Value of the 340B Program Act Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---Transfer of Authority for National Strategic Stockpile ------S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 6378/S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA) ---National Biodefense Strategy Biosimilars ---Access to Samples for Testing ---Coding ---Naming ---Interchangeability and Pharmacy Substitution ---S. 974/H.R. 2212: CREATES Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Patient-Focused Drug Development ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---FDA Management & Financial Accountability ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---Counterfeiting Drug Pricing ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Drug Product Communications ---H.R. 1703: The Medical Products Communications Act of 2017 ---S. 2157: Drug-Price Transparency in Communications Act ---Direct to Consumer Advertising Disclosures ------H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ------H.R. 6157: Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 Foreign Drug Data Protection Laws Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for FDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---S. 974/H.R. 2212: CREATES Act of 2017 ---H.R. 749: Lower Drug Costs Through Competition Act Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---IP Provisions Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Orphan Drug Issues ---Tax Credit Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6505: Medicare Negotiation and Competitive Licensing Act of 2018 Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11.FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12.FY 2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13.Consolidated Appropriations Act 2018 (Public Law 115-141) 14.Midnight Rules Relief Act (S.34/H.R. 21) 15.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18.Regulatory Integrity Act (H.R. 1004) 19.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21.American Health Care Act (H.R. 1628/H.Res. 228) 22.Ozone Standards Implementation Act (S. 263/H.R. 806) 23.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27.Preventing Antibiotic Resistance Act (S. 629) 28.Better Care Reconciliation Act (H.R. 1628) and related amendments 29.Public Health Emergency Response Act (S. 196) 30.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31.Consolidated Appropriations Act, 2017 (Public Law 115-31) 32.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35.Tobacco Tax Equity Act (S. 1837) 36.Healthy Kids Act (S. 1821/H.R. 3921) 37.Implementation of the Drug Quality and Security Act (P.S. 113-54) 38.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40.Lead-Safe Housing for Kids Act (S. 1845) 41.Supporting Working Moms Act (S. 2122/H.R. 3255) 42.Championing Healthy Kids Act (H.R. 3922) 43.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 44.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45.Tax Cuts and Jobs Act (Public Law 115-97) 46.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) 47.Vaccine Access Improvement Act (H.R. 4993) 48.Relief from New Source Performance Standards Act (H.R. 453) 49.Strategies to Address Antimicrobial Resistance (S. 2469) 50.Opioid Quota Reform Act (S. 2535) 51.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 53.Health Equity and Accountability Act (H.R. 5942) 54.Opioid Crisis Response Act of 2018 (S. 2680) 55.Agriculture and Nutrition Act (H.R. 2) 56.Agriculture Improvement Act (S. 3042) 57.SECURE Act (H.R. 5998) 58.FY 2019 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 3158) 59.FY 2019 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 6147/S. 3073) 60.FY 2019 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 5961/ S. 2976) 61.Trauma-Informed Care for Children and Families Act (S. 774) 62.SUPPORT for Patients and Communities Act (H.R. 6) 63.Centers for Disease Control Emergency Response Act (S. 3161) 64.LABEL Opioids Act (S. 3428) 65.Relief from New Source Performance Standards Act (S. 1857) 66.Outdoors for All Act (S. 3499) 67.The MOMMA Act (H.R. 5977) 68.The WIC Act (not yet introduced) 69.Preventing Maternal Deaths Act (H.R. 1318) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11.FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12.FY 2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13.Consolidated Appropriations Act 2018 (Public Law 115-141) 14.Midnight Rules Relief Act (S.34/H.R. 21) 15.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18.Regulatory Integrity Act (H.R. 1004) 19.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21.American Health Care Act (H.R. 1628/H.Res. 228) 22.Ozone Standards Implementation Act (S. 263/H.R. 806) 23.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27.Preventing Antibiotic Resistance Act (S. 629) 28.Better Care Reconciliation Act (H.R. 1628) and related amendments 29.Public Health Emergency Response Act (S. 196) 30.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31.Consolidated Appropriations Act, 2017 (Public Law 115-31) 32.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35.Tobacco Tax Equity Act (S. 1837) 36.Healthy Kids Act (S. 1821/H.R. 3921) 37.Implementation of the Drug Quality and Security Act (P.S. 113-54) 38.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40.Lead-Safe Housing for Kids Act (S. 1845) 41.Supporting Working Moms Act (S. 2122/H.R. 3255) 42.Championing Healthy Kids Act (H.R. 3922) 43.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 44.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45.Tax Cuts and Jobs Act (Public Law 115-97) 46.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6783) 47.Vaccine Access Improvement Act (H.R. 4993) 48.Relief from New Source Performance Standards Act (H.R. 453) 49.Strategies to Address Antimicrobial Resistance (S. 2469) 50.Opioid Quota Reform Act (S. 2535) 51.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52.Relief from New Source Performance Standards Act (H.R. 453) 53.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 54.Health Equity and Accountability Act (H.R. 5942) 55.Opioid Crisis Response Act of 2018 (S. 2680) 56.Agriculture and Nutrition Act (H.R. 2) 57.Agriculture Improvement Act (S. 3042) 58.SECURE Act (H.R. 5998) 59.FY 2019 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 3158) 60.FY 2019 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 6147/S. 3073) 61.FY 2019 Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations (H.R. 5961/ S. 2976) 62.Trauma-Informed Care for Children and Families Act (S. 774) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

340B Drug Discount Program ---Program Implementation & Oversight ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---H.R. 4710: 340B Pause Act ---H.R. 5598: 340B Optimization Act ---S. 2453: Ensuring the Value of the 340B Program Act Access to Medicines/World Health Organization Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) ---S.2852: Pandemic and All-Hazards Preparedness and Innovation Act (PAHPAIA) Biosimilars ---Access to Samples for Testing ---Interchangeability and Pharmacy Substitution ---S. 974/H.R. 2212: CREATES Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Innovation Incentives ---Patient-Focused Drug Development ---S.204 / H.R. 878: Right to Try Act of 2017 ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---FDA Management & Financial Accountability ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---S.469: Affordable and Safe Prescription Drug Importation Act Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---Counterfeiting Drug Pricing ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs Drug Product Communications Foreign Drug Data Protection Laws Funding for Antimicrobial Resistance Programs ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for FDA ---H.R. 5961/S.2976: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2019 Funding for National Institutes of Health ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---S.3158: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2019 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---S. 974/H.R. 2212: CREATES Act of 2017 Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---IP Provisions Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Transparency ---H.R. 5590: Opioid Addiction Action Plan Act ---H.R. 5002: Advancing Cutting Edge Research Act ---H.R. 5473: Better Pain Management Through Better Data Act ---H.R. 5806: 21st Century Tools for Pain Addiction Treatment ---H.R. 6: SUPPORT for Patients and Communities Act ---S.2665: Providing Clarity in Development of Pain Treatment ---S.2669: Advancing Innovation in Alternative Pain and Addiction Therapies Act ---S.2680: Opioid Crisis Response Act ---S.2769: HEAL Act Orphan Drug Issues ---Tax Credit Reimbursement for Innovative Products ---HHS Blueprint to lower drug prices and reduce out of pocket costs ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 771: Improving Access to Affordable Prescription Drugs ---H.R. 6142/S. 2042: Reducing Drug Waste Act Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education ---H.R. 4993: Vaccine Access Improvement Act

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addiction and Recovery Act (Public Law 114-98) 11.FY 2018 Departments of Labor, Health, and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12.FY 2018 Departments of Agriculture, Rural Development, Food, and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13.Consolidated Appropriations Act 2018 (Public Law 115-141) 14.Midnight Rules Relief Act (S.34/H.R. 21) 15.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18.Regulatory Integrity Act (H.R. 1004) 19.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20.A concurrent resolution setting forth the congressional budget for the United States Government for the fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21.American Health Care Act (H.R. 1628/H.Res. 228) 22.Ozone Standards Implementation Act (S. 263/H.R. 806) 23.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27.Preventing Antibiotic Resistance Act (S. 629) 28.Better Care Reconciliation Act (H.R. 1628) and related amendments 29.Public Health Emergency Response Act (S. 196) 30.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31.Consolidated Appropriations Act, 2017 (Public Law 115-31) 32.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35.Tobacco Tax Equity Act (S. 1837) 36.Healthy Kids Act (S. 1821/H.R. 3921) 37.Implementation of the Drug Quality and Security Act (P.S. 113-54) 38.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40.Lead-Safe Housing for Kids Act (S. 1845) 41.Supporting Working Moms Act (S. 2122/H.R. 3255) 42.Championing Healthy Kids Act (H.R. 3922) 43.Making further continuing appropriations for the fiscal year 2018, and for other purposes (Public Law 115-90) 44.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45.Tax Cuts and Jobs Act (Public Law 115-97) 46.Reauthorization of the Pandemic and All-Hazards Preparedness Act (not yet introduced) 47.Vaccine Access Improvement Act (H.R. 4993) 48.Relief from New Source Performance Standards Act (H.R. 453) 49.Strategies to Address Antimicrobial Resistance (S. 2469) 50.Opioid Quota Reform Act (S. 2535) 51.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52.Relief from New Source Performance Standards Act (H.R. 453) 53.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 54.Health Equity and Accountability Act (not yet introduced) 55.Opioid Crisis Response Act of 2018 (not yet introduced) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

340B Drug Discount Program ---Program Implementation & Oversight ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 4710: 340B Pause Act ---S. 2453: Ensuring the Value of the 340B Program Act Access to Medicines/World Health Organization Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Act of 2017 (Reps. Brooks/Eshoo Discussion Draft) Biosimilars ---S. 974/H.R. 2212: CREATES Act of 2017 ---Access to Samples for Testing ---Columbia Biologics Regulation ---Coding ---H.R. 1892: Bipartisan Budget Act of 2018 ---H.R. 1625: Consolidated Appropriations Act for FY 2018 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Proposed Rule on Changes to Drug Labeling ---Innovation Incentives ---Patient-Focused Drug Development ---S.204 / H.R. 878: Right to Try Act of 2017 ---Prescription Drug User Fee Act (PDUFA) VI Implementation ---Biosimilar User Fee Amendments (BSUFA) II Implementation ---FDA Hiring Flexibility ---Priority Review Voucher Program ---Regulatory Reform & Modernization ---Use of Real World Evidence Drug Importation ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act Drug Manufacturing, Quality & Distribution ---Pharmacy Compounding & Oversight ---Drug Shortages ---Supply Chain Integrity and Traceability ---H.R. 2871: Preserving Patient Access to Compound Medications Drug Pricing ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs Drug Product Communications ---H.R. 1703: The Medical Products Communications Act ---H.R. 2026: Pharmaceutical Information Exchange Act Foreign Drug Data Protection Laws Funding for Antimicrobial Resistance Programs ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for FDA ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act ---H.R. 749: Lower Drug Costs through Competition Act ---S. 974/H.R. 2212: CREATES Act of 2017 ---H.R. 1892: Bipartisan Budget Act of 2018 ---H.R. 1625: Consolidated Appropriations Act for FY 2018 Independent Payment Advisory Board Repeal ---H.R. 849/S. 260: Protecting Seniors' Access to Medicare Act ---H.R. 1892: Bipartisan Budget Act of 2018 ---H.R. 1625: Consolidated Appropriations Act for FY 2018 International Biosecurity Policies Medicaid ---Drug Benefit Design ---Pricing and Rebates ---Average Manufacturer Price Calculations North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---IP Provisions Opioid Crisis ---NIH Research ---FDA Reforms ---Coverage and Reimbursement ---Discussion Drafts House/Senate Orphan Drug Issues ---Technical Amendments ---Tax Credit Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---CMS Hospital Inpatient Proposed Rule ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---H.R. 242: Medicare Prescription Drug Price Negotiation Act ---H.R. 4138: Medicare Drug Price Negotiation Act ---H.R. 1892: Bipartisan Budget Act of 2018 ---H.R. 1625: Consolidated Appropriations Act for FY 2018 Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety ---Adult Immunization Education ---H.R. 4993: Vaccine Access Improvement Act

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addiction and Recovery Act (Public Law 114-98) 11.FY 2018 Departments of Labor, Health, and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12.FY 2018 Departments of Agriculture, Rural Development, Food, and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13.Consolidated Appropriations Act 2018 (Public Law 115-141) 14.Midnight Rules Relief Act (S.34/H.R. 21) 15.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 16.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 17.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 18.Regulatory Integrity Act (H.R. 1004) 19.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 20.A concurrent resolution setting forth the congressional budget for the United States Government for the fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 21.American Health Care Act (H.R. 1628/H.Res. 228) 22.Ozone Standards Implementation Act (S. 263/H.R. 806) 23.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 24.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 25.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 26.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 27.Preventing Antibiotic Resistance Act (S. 629) 28.Better Care Reconciliation Act (H.R. 1628) and related amendments 29.Public Health Emergency Response Act (S. 196) 30.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 31.Consolidated Appropriations Act, 2017 (Public Law 115-31) 32.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 33.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 34.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 35.Tobacco Tax Equity Act (S. 1837) 36.Healthy Kids Act (S. 1821/H.R. 3921) 37.Implementation of the Drug Quality and Security Act (P.S. 113-54) 38.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 39.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 40.Lead-Safe Housing for Kids Act (S. 1845) 41.Supporting Working Moms Act (S. 2122/H.R. 3255) 42.Championing Healthy Kids Act (H.R. 3922) 43.Making further continuing appropriations for the fiscal year 2018, and for other purposes (Public Law 115-90) 44.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 45.Tax Cuts and Jobs Act (Public Law 115-97) 46.Reauthorization of the Pandemic and All-Hazards Preparedness Act (not yet introduced) 47.Vaccine Access Improvement Act (H.R. 4993) 48.Relief from New Source Performance Standards Act (H.R. 453) 49.Strategies to Address Antimicrobial Resistance (S. 2469) 50.Opioid Quota Reform Act (S. 2535) 51.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 52.Relief from New Source Performance Standards Act (H.R. 453) 53.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 54.Health Equity and Accountability Act (not yet introduced) 55.Opioid Crisis Response Act of 2018 (not yet introduced) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

Tax incentives on research into antibiotics, antifungals, and infectious disease diagnostic tests. H.R. 1840.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Tax incentives on research into antibiotics, antifungals, and infectious disease diagnostic tests. H.R. 1840.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Tax incentives on research into antibiotics, antifungals, and infectious disease diagnostic tests. H.R. 1840. H.R. 1, Tax Cuts and Jobs Act.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension Capital Formation Investment Incentives ---An Act to Modify Net Operating Loss Carryforwards (House Discussion Draft) ---H.R. 2297: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules Corporate Tax Reform Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---Investment Tax Credit ---Production Tax Credit ---HR 3149: Renewable Chemicals Act of 2017 ---The Master Limited Partnership Act (Sen. Coons' Discussion Draft) ---The Renewable Chemicals Act (Sen. Coons' Discussion Draft) Research & Development Tax Credit Reforms ---Extension ---Permanency ---Refundable R&D Credit Treatment of Financial Interests as Stock or Indebtedness ---Section 385 Proposed Regulations

Client expense: $2,380,000 · Firm income: Not reported

340B Drug Discount Program ---340B Program Reforms (Rep. C. Collins Discussion Draft) ---Program Implementation & Oversight ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Affordable Care Act - Repeal and Replace ---The Better Care Reconciliation Act of 2017 (Senate Discussion Draft) Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Asia Pacific Economic Cooperation Forum ---Biologics Regulations Biodefense Research, Development and Procurement Issues (Non-funding) ---Tropical Disease Priority Review Voucher (PRV) Program ---Implementation of Medical Countermeasures Innovation Act ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Brazil Biologics Regulations ---Coding ---India Biologics Regulations ---Interchangeability and Pharmacy Substitution ---Mexico Biologics Regulations ---Naming ---Patent Certification ---S. 974/H.R. 2212: CREATES Act of 2017 ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---FDA Proposed Rule on Changes to Drug Labeling ---Government Hiring Freeze ---Innovation Incentives ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---Reauthorization of the Prescription Drug User Fee Act ---Regulatory Reform & Modernization ---Use of Real-World Evidence ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 ---S.204 / H.R. 878: Right to Try Act of 2017 ---S.456 / H.R. 1231: RACE for Children Act Drug Importation ---Welch Amendment to H.R. 2430: FDA Reauthorization Act of 2017 ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 ---S.469: Affordable and Safe Prescription Drug Importation Act ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Drug Manufacturing, Quality & Distribution ---Counterfeiting ---Drug Shortages ---Pharmacy Compounding & Oversight ---Supply Chain Integrity and Traceability Drug Pricing ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S. 1369 / H.R. 2974: Stop Price Gouging Act ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---S. 771: Improving Access to Affordable Prescription Drugs ---S. 934/H.R. 2430: FDA Reauthorization Act of 2017 ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 ---S. 1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services Drug Product Communications ---The Medical Products Communications Act of 2017 (Rep. Griffith Discussion Draft) ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 Funding for Antimicrobial Resistance Programs ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R. 3219: Department of Defense Appropriations Act for FY 2018 ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Funding for FDA ---H.R. 3268/S.1603: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Funding for National Institutes of Health ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R. 3358/S.1771: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---H.R. 3354: Omnibus Appropriations Act for FY 2018 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act ---H.R. 749: Lower Drug Costs through Competition Act ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 ---S. 974/H.R. 2212: CREATES Act of 2017 Independent Payment Advisory Board Repeal ---S. 260: Protecting Seniors' Access to Medicare Act Medicaid ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates ---Section 1115 Waivers North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---Regulatory Harmonization ---IP Provisions Opioid Crisis Orphan Drug Issues ---Technical Amendments ---Tax Credit ---S. 934 / H.R. 2430: FDA Reauthorization Act of 2017 ---S.456 / H.R. 1231: RACE for Children Act Reauthorization of Children's Health Insurance Program ---H.R. 3921: The HEALTHY KIDS Act of 2017 Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications ---S. 1688: Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017 Trade and Foreign Drug Price Controls UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions and prescription drug abuse. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11.FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (S. 1771/H.R. 3358) 12.FY 2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (S. 1603/H.R. 3268) 13.Midnight Rules Relief Act (S.34/H.R. 21) 14.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 15.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 16.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 17.Regulatory Integrity Act (H.R. 1004) 18.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 19.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 20.American Health Care Act (H.R. 1628/H.Res. 228) 21.Ozone Standards Implementation Act (S. 263/H.R. 806) 22.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 23.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 24.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 25.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 26.Preventing Antibiotic Resistance Act (S. 629) 27.Better Care Reconciliation Act (H.R. 1628) and related amendments 28.Public Health Emergency Response Act (S. 196) 29.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 30.Consolidated Appropriations Act, 2017 (Public Law 115-31) 31.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 32.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 33.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 34.Tobacco Tax Equity Act (S. 1837) 35.Healthy Kids Act (S. 1821/H.R. 3921) 36.Implementation of the Drug Quality and Security Act (P.S. 113-54) 37.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEM

Tax incentives on research into antibiotics, antifungals, and infectious disease diagnostic tests. H.R. 1840.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions and prescription drug abuse. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of the FDA Food Safety Modernization Act (Public Law 111-353) 3.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act (Public Law 113-5) 4.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 5.Implementation of the Budget Control Act of 2011 (Public Law 112-25) 6.Implementation of the Drug Quality and Security Act of 2013 (Public Law 113-54) 7.Implementation of Animal Drug and Animal Generic Drug User Fee Act (Public Law 113-14) 8.Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 9.Implementation of Every Student Succeeds Act (Public Law 114-95) 10.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 11.FY 2017 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations 12.FY 2018 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations 13.FY2017 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations 14.FY2018 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations 15.Midnight Rules Relief Act (S.34/H.R. 21) 16.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 17.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 18.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 19.Regulatory Integrity Act (H.R. 1004) 20.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 21.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 22.American Health Care Act (H.R. 1628/H.Res. 228) 23.Ozone Standards Implementation Act (S. 263/H.R. 806) 24.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 25.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 26.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 27.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 28.Preventing Antibiotic Resistance Act (S. 629) 29.Better Care Reconciliation Act (H.R. 1628) 30.Public Health Emergency Response Act (S. 196) 31.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 32.Consolidated Appropriations Act, 2017 (Public Law 115-31) 33.Treat and Reduce Obesity Act (S. 830/H.R. 1953) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, Education, USDA, DHS, FEMA, and SAMHSA.

340B Drug Discount Program ---340B Program Reforms (Rep. C. Collins Discussion Draft) ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Program Implementation & Oversight Affordable Care Act - Repeal and Replace ---H.R. 1628: American Health Care Act ---The Better Care Reconciliation Act of 2017 (Senate Discussion Drafts) Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biodefense Research, Development, and Procurement Issues (Nonfunding) ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Implementation of Medical Countermeasures Innovation Act ---Tropical Disease Priority Review Voucher (PRV) Program ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Brazil Biologics Regulations ---Coding ---India Biologics Regulations ---Interchangeability and Pharmacy Substitution ---Mexico Biologics Regulations ---Naming ---Patent Certification ---S. 974/H.R. 2212: CREATES Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---FDA Proposed Rule on Changes to Drug Labeling ---Government Hiring Freeze ---Innovation Incentives ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---Regulatory Reform & Modernization ---Reauthorization of the Prescription Drug User Fee Act ---Special Medical Use/Limited Population Drug ---Use of Real-World Evidence ---S.204 -H.R. 878: Rights to Try Act of 2017 ---S.456 - H.R. 1231: RACE for Children Act ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Importation ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---Welch Amendment to: H.R. 2430: FDA Reauthorization Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Manufacturing, Quality & Distribution ---Counterfeiting ---Drug Shortages ---Pharmacy Compounding & Oversight ---Supply Chain Integrity and Traceability Drug Pricing ---S. 771: Improving Access to Affordable Prescription Drugs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Product Communications ---The Medical Products Communications Act of 2017 (Rep. Griffith Discussion Draft) ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Funding for Antimicrobial Resistance Programs ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---Department of Defense Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for FDA ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act ---H.R. 749: Lower Drug Costs through Competition Act ---S. 974/H.R. 2212: CREATES Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Medicaid ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---Regulatory Harmonization ---IP Provisions Orphan Drug Issues ---RACE for Children Act (Discussion Draft) ---Tax Credit ---Technical Amendments ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---H.R. 1628: American Health Care Act ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety Foreign Drug Data Protection Laws ---Israel Trade and Foreign Drug Price Controls

Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension Capital Formation Investment Incentives ---An Act to Modify Net Operating Loss Carryforwards (House Discussion Draft) ---H.R. 2297: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---Expansion of Master Limited Partnerships to Renewable Chemicals ---HR 3149: Renewable Chemicals Act of 2017 Research & Development Tax Credit Reforms ---Refundable R&D Credit Treatment of Financial Interests as Stock or Indebtedness ---Section 385 Proposed Regulations Corporate Tax Reform

Client expense: $2,350,000 · Firm income: Not reported

Tax incentives on research into antibiotics, antifungals, and infectious disease diagnostic tests. H.R. 1840.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

21st Century Cures Act Implementation ---Biomarkers and Regulatory Science Improvements ---Communication with Healthcare Professionals and Payors ---Expanded Access to Investigational Drugs ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---Government Hiring Freeze ---Innovation Incentives ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---Use of Real-World Evidence 340B Drug Pricing Program ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Program Implementation & Oversight Affordable Care Act - Repeal and Replace ---H.R. 1628: American Health Care Act ---Vaccine Issues Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biodefense Research, Development, and Procurement Issues (Nonfunding) ---Implementation of Medical Countermeasures Innovation Act Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Coding ---Interchangeability and Pharmacy Substitution ---Naming Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Government Hiring Freeze ---Regenerative Medicine ---Implementation of the FDA Safety and Innovation Act ---RACE for Children Act (Discussion Draft) ---Reauthorization of the Prescription Drug User Fee Act ---S.204/H.R.878: Right to Try Act of 2017 Drug Importation ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S.469: Affordable and Safe Prescription Drug Importation Act ---S.Amdt.174 to S.Con.Res.3 ---S.Amdt.178 to S.Con.Res.3: Drug Manufacturing, Quality & Distribution ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Implementation of H.R. 3204: The Drug Quality and Security Act ---Pharmacy Compounding & Oversight ---Supply Chain Integrity and Traceability ---Vial and Dose Size Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Continuing Appropriations Act for FY 2017 Funding for Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Continuing Appropriations Act for FY 2017 Funding for FDA ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Continuing Appropriations Act for FY 2017 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Continuing Appropriations Act for FY 2017 Generic Drug Entry ---Access to Samples for Testing ---Incentives for Generic Entry Generic Drug Application Review Reforms ---H.R. 749: Lower Drug Costs Through Competition Act ---S. 297: Increasing Competition in Pharmaceuticals Act Government Price Reporting ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Independent Payment Advisory Board Medicaid Pricing and Rebates ---Average Manufacturer Price Calculations Orphan Drug Act Tax Credit Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---Value-based Contracting and Communications Turkish Requirement for Localized Drug Manufacturing UN High Level Commission on Access to Medicines Vaccines and Infectious Diseases ---Vaccine Injury Compensation Program ---Vaccine Safety Combating Antibiotic-Resistant Bacteria (CARB) Initiative ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Continuing Appropriations Act for FY 2017 Drug Pricing ---S.Amdt.188 to S.Con.Res.3 ---S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act ---The Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act (Senator Wyden Discussion Draft) ---Drug Price Gouging Enforcement (Senator Coons Discussion Draft) ---S. 771: Improving Access to Affordable Prescription Drugs Opioid Abuse Longitudinal Study of Chronic Diseases

Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension Capital Formation Investment Incentives ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---An Act to Modify Net Operating Loss Carryforwards (House Discussion Draft) Orphan Drug Act Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---New Production Tax Credit

Client expense: $2,300,000 · Firm income: Not reported

Tax incentives on research into antibiotics, antifungals, and infectious disease diagnostic tests. H.R. 1840.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE